tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX
Holding TVTX?
Track your performance easily

Travere Therapeutics (TVTX) Income Statement

360 Followers

Travere Therapeutics Income Statement

Last quarter (Q2 2024), Travere Therapeutics's total revenue was $54.12M, a decrease of -5.08% from the same quarter last year. In Q2, Travere Therapeutics's net income was $-70.41M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 177.64M$ 145.24M$ 212.02M$ 227.49M$ 198.32M$ 175.34M
Cost of Revenue
$ 9.42M$ 11.45M$ -7.59M$ -6.78M$ 6.13M$ 5.23M
Gross Profit
$ 168.23M$ 133.79M$ 189.42M$ 198.45M$ 192.19M$ 170.10M
Operating Expense
$ 467.68M$ 510.53M$ 455.99M$ 360.21M$ 267.57M$ 269.91M
Operating Income
$ -420.45M$ -388.14M$ -266.57M$ -161.76M$ -75.38M$ -99.81M
Net Non Operating Interest Income Expense
$ 15.16M$ 10.43M$ -5.00M$ -18.15M$ -14.05M$ -8.77M
Other Income Expense
$ 1.55M$ -9.80M$ 6.60M$ -231.00K$ -99.37M$ -37.87M
Pretax Income
$ -409.63M$ -376.11M$ -278.17M$ -179.68M$ -188.79M$ -146.45M
Tax Provision
$ 356.00K$ 223.00K$ 313.00K$ 409.00K$ -19.36M$ -21.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -385.88M$ -111.40M$ -278.48M$ -180.09M$ -169.43M$ -146.43M
Basic EPS
$ -1.88$ -1.50$ -4.37$ -3.01$ -3.56$ -3.46
Diluted EPS
$ -1.88$ -1.50$ -4.37$ -3.01$ -3.56$ -3.46
Basic Average Shares
$ 307.53M$ 74.27M$ 63.76M$ 59.83M$ 47.54M$ 42.34M
Diluted Average Shares
$ 307.53M$ 74.27M$ 63.76M$ 59.83M$ 47.54M$ 42.34M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----$ -2.88-
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 480.60M$ 521.98M$ 448.39M$ 353.43M$ 273.70M$ 275.15M
Net Income From Continuing And Discontinued Operation
$ -145.91M$ -111.40M$ -278.48M$ -180.09M$ -169.43M$ -146.43M
Normalized Income
$ -218.52M$ -282.33M--$ -78.98M$ -108.88M
Interest Expense
----$ 19.05M$ 18.83M
EBIT
$ -306.68M$ -364.78M$ -289.47M$ -161.53M$ -169.74M$ -127.62M
EBITDA
$ -190.53M$ -326.25M$ -254.77M$ -123.67M$ -145.16M$ -107.21M
Currency in USD

Travere Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis